Founder of CML Network optimistic for Niagara residents
Some good news for people in Niagara living with a rare type of blood cancer.... chronic myeloid leukemia.
Lisa Machado is Founder of Canada's CML Network, and says the latest drug Scemblix is changing this from a terminal illness to manageable.
She adds sometimes the cancer goes into remission. "I could actually try treatment free remission, but it's a whole other policy issue in that they don't pay for the monitoring here in Ontario. I would have to be monitored quite often if I stopped taking the medication, and that's not an option for me right now."
She was diagnosed in 2008, after looking into a bruise that wouldn't heal.
"Characterized by lots of white cells in your blood, and you need a medication, a type of chemo, to keep them in check."
She's been taking another drug since first diagnosed.
Public Health Asking for $42-Mill
Fort Erie Increasing Pressure on Niagara Health
Young Offender Arrested in Vape Store Theft
150th Birthday Celebrated at Montebello Park
City Encouraged to Go After Funding
Cost of Renewing Vows Could Rise
GM Investing in St. Catharines
NRP Investigating Fatal Pelham Crash